Company Search:
Advanced Search
Sponsored Links
Alembic Pharmaceuticals Ltd Company Snapshot
Alembic Pharmaceuticals Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alembic Pharmaceuticals Ltd with three other companies in this sector in INDIA : IPCA Laboratories Limited (2021 sales of 54.20 billion Indian Rupees [US$731.16 million] ), Laurus Labs Ltd (48.14 billion Indian Rupees [US$649.34 million] ), and Jubilant Pharmova Ltd (60.99 billion Indian Rupees [US$822.69 million] ).

Sales Analysis. Alembic Pharmaceuticals Ltd reported sales of 53.93 billion Indian Rupees (US$727.53 million) for the fiscal year ending March of 2021. This represents an increase of 17.1% versus 2020, when the company's sales were 46.06 billion Indian Rupees . This was the fourth straight year of sales growth at Alembic Pharmaceuticals Ltd. Sales of Api saw an increase that was more than double the company's growth rate: sales were up 34.9% in 2021, from 7.08 billion Indian Rupees to 9.55 billion Indian Rupees .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Alembic Pharmaceuticals Ltd
  Stock Performance Chart for Alembic Pharmaceuticals Ltd
  Stock Data: Recent Stock Performance:
  Current Price (6/18/2021): 976.05
(Figures in Indian Rupees )
1 Week -3.0%   13 Weeks 2.0%  
4 Weeks 10.0%   52 Weeks 3.1%  
Alembic Pharmaceuticals Ltd Key Data:
  Ticker: APLLTD Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2021 Sales 53,931,200,000
(Year Ending Jan 2022).
Employees: 12,160
  Currency: Indian Rupees Market Cap: 191,855,437,180
  Fiscal Yr Ends: March Shares Outstanding: 196,563,124
  Share Type: Ordinary Closely Held Shares: 137,780,508
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.